KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD-Reference-Cited by-同舟云学术

KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

Published:2023-12 Issue: Volume: Page:
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Mottl Amy K.,Nicholas Susanne B.

Publisher

Elsevier BV

Subject

Nephrology

Reference72 articles.

1. Executive summary of the 2020 KDIGO Diabetes Management in CKD guideline: evidence-based advances in monitoring and treatment;De Boer;Kidney Int,2020

2. Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence;Rossing;Kidney Int,2022

3. Nutrition therapy for adults with diabetes or prediabetes: a consensus report;Evert;Diabetes Care,2019

4. National trends in use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists by cardiologists and other specialties, 2015 to 2020;Adhikari;J Am Heart Assoc,2022

5. The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the charge;Norgard;Postgrad Med,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary sodium modulates mTORC1-dependent trained immunity in macrophages to accelerate CKD development;Biochemical Pharmacology;2024-11

2. Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney;Blood Pressure;2024-06-23

3. Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases;Frontiers in Endocrinology;2024-02-22